Reported figures and Equlion model projections for the next 5 years.
Metric
2025 (actual)
2026
2027
2028
2029
2030
Trend
ROE
1.23%
0.19%
1.19%
0.91%
1.24%
1.42%
ROA
0.67%
0.1%
0.65%
0.48%
0.62%
0.7%
Gross Margin
77.86%
77.86%
77.86%
77.86%
77.86%
77.86%
Sector average
16.85%
17.71%
17.71%
17.71%
17.71%
17.71%
Net Margin
Amounts in SEK (millions); stock price per share. Values that are missing or fail Equlion's automated data-quality checks are shown as “-”. Stock price and valuation carry no data date: they are the Equlion model's estimate for 2025. Projections are model estimates, not investment advice.
Want the full financial forecast report for Swedish Orphan Biovitrum AB (publ)? It covers the balance sheet, income statement and Equlion model projections.
1.69%
0.24%
1.38%
0.92%
1.13%
1.24%
Total Assets
SEK 67,434.00M
SEK 68,267.89M
SEK 70,768.71M
SEK 74,810.49M
SEK 78,905.32M
SEK 81,337.45M
Sector average
SEK 2,857.19M
SEK 2,900.24M
SEK 3,045.01M
SEK 3,280.29M
SEK 3,536.41M
SEK 3,762.91M
Net Income
SEK 478.00M
SEK 71.13M
SEK 451.44M
SEK 348.93M
SEK 480.09M
SEK 558.52M
Sector average
-SEK 2.85M
-SEK 22.03M
-SEK 0.90M
-SEK 7.25M
-SEK 3.86M
-SEK 1.55M
Valuation
SEK 115,815.92M
SEK 119,502.84M
SEK 121,795.17M
SEK 124,654.40M
SEK 127,139.39M
SEK 129,469.54M
Sector average
SEK 3,960.50M
SEK 5,151.30M
SEK 5,189.24M
SEK 5,317.34M
SEK 5,514.33M
SEK 5,636.78M
Stock Price
SEK 332.80
SEK 343.39
SEK 349.98
SEK 358.20
SEK 365.34
SEK 372.03
Sector average
SEK 57.22
SEK 48.04
SEK 48.69
SEK 50.45
SEK 52.13
SEK 53.41
Swedish Orphan Biovitrum AB (publ) (SOBI.ST) Financial Forecast | Equlion
